Using a nutritional model of NASH (atherogenic diet including cholesterol and cholic acid) [20] and a genetic model of liver fibrosis (Mdr2-/- mice, ABCB4 KO mice), we showed that the hepatic cholesterol level regulates the disease phenotype. This evidence concerns the gene ABCB4 and metabolic dysfunction-associated steatohepatitis.